Literature DB >> 2108402

Both Jun and Fos contribute to transcription activation by the heterodimer.

S Hirai1, B Bourachot, M Yaniv.   

Abstract

Comparison of the amino acid sequence of the three members of the mouse jun proto-oncogene family, c-jun, jun B and jun D, reveals several homologous segments. The most C-terminal of them including a leucine zipper motif and a cluster of basic amino acids was previously identified as the DNA binding domain. By deletion analysis, we show that three conserved domains in the N-terminal region are crucial for transactivation by Jun homodimers. Only one of these is predicted to form an acidic amphipathic alpha-helix. The addition of Fos and the formation of Jun-Fos heterodimers strongly increases the transactivation level. Jun mutants that are inactive alone gain partial or full activity in the presence of Fos. This increase strongly depends on the presence of the C-terminal domain of Fos. These results show that in Jun-Fos heterodimers both the N-terminal part of Jun and the C-terminal part of Fos contribute to transactivation with a more pronounced role for the latter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108402

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers.

Authors:  M Pariat; C Salvat; M Bébien; F Brockly; E Altieri; S Carillo; I Jariel-Encontre; M Piechaczyk
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

2.  Two rice MADS domain proteins interact with OsMADS1.

Authors:  J Lim; Y H Moon; G An; S K Jang
Journal:  Plant Mol Biol       Date:  2000-11       Impact factor: 4.076

3.  alphaNAC requires an interaction with c-Jun to exert its transcriptional coactivation.

Authors:  Isabelle Quèlo; Mélanie Hurtubise; René St-Arnaud
Journal:  Gene Expr       Date:  2002

4.  Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes.

Authors:  F Thierry; G Spyrou; M Yaniv; P Howley
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 5.  Fos-jun and the primary genomic response in the nervous system. Possible physiological role and pathophysiological significance.

Authors:  J P Doucet; S P Squinto; N G Bazan
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

6.  Selective interaction of JNK protein kinase isoforms with transcription factors.

Authors:  S Gupta; T Barrett; A J Whitmarsh; J Cavanagh; H K Sluss; B Dérijard; R J Davis
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

7.  The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells.

Authors:  R Alani; P Brown; B Binétruy; H Dosaka; R K Rosenberg; P Angel; M Karin; M J Birrer
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

8.  Effect of ultraviolet B radiation on activator protein 1 constituent proteins and modulation by dietary energy restriction in SKH-1 mouse skin.

Authors:  Brian D Hopper; Joseph Przybyszewski; Haw-Wen Chen; Kimberly D P Hammer; Diane F Birt
Journal:  Mol Carcinog       Date:  2009-09       Impact factor: 4.784

9.  The oncogene c-Jun impedes somatic cell reprogramming.

Authors:  Jing Liu; Qingkai Han; Tianran Peng; Meixiu Peng; Bei Wei; Dongwei Li; Xiaoshan Wang; Shengyong Yu; Jiaqi Yang; Shangtao Cao; Kaimeng Huang; Andrew Paul Hutchins; He Liu; Junqi Kuang; Zhiwei Zhou; Jing Chen; Haoyu Wu; Lin Guo; Yongqiang Chen; You Chen; Xuejia Li; Hongling Wu; Baojian Liao; Wei He; Hong Song; Hongjie Yao; Guangjin Pan; Jiekai Chen; Duanqing Pei
Journal:  Nat Cell Biol       Date:  2015-06-22       Impact factor: 28.824

10.  The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.

Authors:  K McBride; M Nemer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.